Skip to main content

Find Clinical Trials

Home
Conditions
Gliomas Harboring IDH1 and/or IDH2 Mutations

Clinical trial condition

Gliomas Harboring IDH1 and/or IDH2 Mutations

Explore clinical trials studying Gliomas Harboring IDH1 and/or IDH2 Mutations. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Gliomas Harboring IDH1 and/or IDH2 Mutations trial results

Recruiting

Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

NCT07608003

Conditions: Astrocytoma, Glioblastoma, Glioma, +13 more
Locations: Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Recruiting

Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations

NCT07025018

Conditions: Glioma, Gliomas Harboring IDH1 and/or IDH2 Mutations, Neoplasms, +6 more
Locations: Huashan Hospital affiliated to Fudan University Shanghai, Shanghai Municipality, China

View Trial Details